Investigation of physicochemical changes to L-Asparaginase during freeze-thaw cycling

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 5, 1997, Pages 472-477

  Jameel, Feroz ^a   Bogner, Robin ^a   Mauri, Frank ^a   Kalonia, Devendra ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BACTERIAL ENZYME;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME DENATURATION; ENZYME STABILITY; ENZYME STRUCTURE; ERWINIA; FREEZING; GEL PERMEATION CHROMATOGRAPHY; LIGHT SCATTERING; LYMPHATIC LEUKEMIA; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SECONDARY STRUCTURE; TEMPERATURE SENSITIVITY; THAWING; THERMOSTABILITY;

EID: 0030917691     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06826.x     Document Type: Article

References (25)

1. Andrade, M. A., Chacon, P., Merelo, J. J., Moran, F. (1993) Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng. 5: 383-390
2. Bertolone, S. J., Fuenfer, M. M., Groff, D. B., Patel, C. C. (1982) Delayed pancreatic pseudocyst formation; long term complication of L-Asparaginase treatment. Cancer 50: 2964-2966
3. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
4. Broome, J. D. (1961) Evidence that the L-Asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. Nature (London) 191: 1114-1115
5. Broome, J. D. (1963) Evidence that the L-Asparaginase of guinea pig serum is responsible for its antilymphoma effects. J. Exp. Med. 118: 99-120
6. Capizzi, R. L., Bertino, J. R., Skeel, R. T., Creasey, W. A., Zanes, R., Olayon, C., Peterson, R. G., Handschumacher, R. E. (1971) L-Asparaginase; clinical, biochemical, pharmacological and immunological studies. Ann. Intern. Med. 74: 893-901
7. Charles, L. M., Bono Jr, V. H. (1981) A review of preclinical antitumor activity and toxicity of L-Asparaginase derived from E. coli. Cancer Treat. Rep. 65: 39-46
8. Eden, O. B., Shaw, M. P., Lilleyman, J., Richards, J. (1988) L-Asparaginase: decreased toxicity with Erwinia Asparaginase used in MRC UKALL VILL. Proc. SIOP, Trandheim
9. Evans, W. E., Tsiatis, A., Rivera, G., Murphy, S. B., Dahl, G. R., Denison, M., Crom, W. R., Barker, L. F., Maurer, A. M. (1982) Anaphylactoid reactions to E. coli and Erwinia Asparaginase in children with leukaemia and lymphoma. Cancer 49: 1378-1383
10. Goldberg, A. E., Cooney, D. A., Glynn, J. P. (1973) The effects of immunization to L-Asparaginase on antitumor and enzymatic activity. Cancer Res. 33: 256-261
11. Gugliotta, L., Mazzucconi, M. G., Leone, G. (1992) Erwinase and haemostatic system in adult ALL patients, preliminary results of a GIGEMA study. Abstr., 24th Congr. Haematology, London, UK, 1470: 388
12. Handschumacher, R. E. (1971) Asparaginase, chemical structure and its relation to disposition and therapeutic efficacy. Proc. C.N.R.S. Int. Symp. L-Asparaginase, Paris, 197: 377
13. Hanafusa, N. (1969) In: Nei, T. (ed.) Freezing and Drying of Microorganisms, University Park Press, Baltimore, pp 117-129
14. Hellman, K., Miller, D. S., Cammack, K. A. (1979) Dissociation of L-Asparaginase by freeze-drying. XIth Int. Congr. Biochemistry, International Union of Biochemistry, Toronto, p. 219
15. Hill, J. M., Roberts, J., Loeb, F. Khan, A., Maclellan, A., Hill, R. B. (1967) L-Asparaginase therapy for leukaemia. J. Am. Med. Assoc. 202: 882-888
16. Hill, J. M., Loeb, F., Maclellan, A., Khan, A., Roberts, J., Shields, W. F., Hill, N. O. (1969) Response to highly purified L-Asparaginase during therapy of acute leukaemia. Cancer Res. 29: 1574-1580
17. Ho, D. H., Brown, N. S., Yen, A., Holmes, R., Keating, M., Abuchowski, A., Newman, R. A., Krakoff, I. H. (1986) Clinical pharmacology of polyethylene glycoL-L-Asparaginase. Drug Metab. Dispos. 14: 349-352
18. Homans, A. C., Rybak, M. E., Baglini, R. L., Tiarks, C., Steiner, M. E., Forman, E. N. (1987) Effect of L-Asparaginase administration on coagulation and platelet function in children with leukaemia. J. Clin. Oncol. 5: 811-817
19. Jameel, F., Kalonia, D., Bogner, R. (1995) The effect of hetastarch on the stability of L-Asparaginase during freeze-thaw cycling. P.D.A. J. Pharm. Sci. Technol. 49: 127-131
20. Jenkins, R., Perlin, E. (1987) Severe hepatotoxicity from E. coli L-Asparaginase. J. Natl Med. Assoc. 79: 775-779
21. Kay, H. E. M., Hamilton-Fairley, G., Knapton, P. J. (1971) The use of different forms of Asparaginase with particular reference to Erwinia carotovorum. Int. Symp. L-Asparaginase. Paris pp 295
22. Kidd, J. G. (1953) Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. J. Exp. Med. 98: 565-583
23. Ohnuma, T., Holland, J. F., Meyer, P. (1972) Erwinia carotovora Asparaginase in patients with prior anaphylaxis to Asparaginase from E. coli. Cancer 30: 376-381
24. Ridgway, D., Neerhout, R. C., Bleyer, A. (1989) Attenuation of Asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the E. coli enzyme preparation. Cancer 63: 561-563
25. Yellin, T. O., Wriston, C. J. (1966) Purification and properties of guinea pig serum Asparaginase. Biochemistry 5: 1605-1612